Clinical Trial Update: A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase 1 safety study evaluating the combination of Velcade (bortezomib) and G-CSF in patients with multiple myeloma or malignant lymphoma unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Lymphoma
• Multiple Myeloma

Drugs mentioned

• Filgrastim (G-CSF) (filgrastim)
• Velcade (bortezomib)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Malignant Lymphoma, Stem Cell Type, Autologous Transplant | EARLY_Phase 1 | Status: COMPLETED